OrganOx Overview
- Founded
- 2008

- Status
- Private
- Employees
- 28

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $8.75M

- Investors
- 12
OrganOx General Information
Description
Developer of organ preservation and transplantation devices designed to minimize liver decay. The company's devices are based on warm preservation that seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells and provide nutrition, enabling healthcare providers to prevent the decay of the organ by producing bile, metabolizing glucose and maintaining a physiological pH.
Contact Information
- Oxford Science Park
- Sherrington Building, Magdalen Centre, Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
OrganOx Timeline
OrganOx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Later Stage VC | 08-Nov-2021 | $8.75M | 0000 | Completed | Generating Revenue | |
9. Later Stage VC | 15-Oct-2021 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
8. Later Stage VC | 08-Jan-2020 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
7. Later Stage VC | 31-Jan-2019 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
6. Later Stage VC | 19-Oct-2018 | 00.000 | 0000 | Completed | Generating Revenue | |
5. Later Stage VC (Series F) | 10-Jun-2014 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
4. Grant | 10-Jun-2013 | 00.000 | Completed | Startup | ||
3. Later Stage VC (Series C) | 09-May-2012 | 00.000 | 00.000 | 000.00 | Completed | Startup |
2. Early Stage VC (Series B) | 07-Feb-2011 | $4.38M | $6.69M | 000.00 | Completed | Startup |
1. Early Stage VC (Series A) | 15-Dec-2008 | $2.31M | $2.31M | 00.00 | Completed | Startup |
OrganOx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.00 | |
Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
Series F | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
Series D | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.00 | |
Series C | 57,560 | $0.013639 | $23.01 | $23.01 | 1x | $23.01 | 4.6% | |
Series B | 179,273 | $0.013639 | $20.92 | $20.92 | 1x | $20.92 | 14.32% |
OrganOx Comparisons
Industry
00000000
000000 0
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialOrganOx Competitors (10)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
TransMedics | Formerly VC-backed | Andover, MA | 000 | 00000 | 00000000 | 00000 |
000000 00000000 | Formerly VC-backed | Wayne, PA | 00 | 00000 | 000000&0 | 00000 |
000000 0000000 000 | Formerly PE-Backed | Rochester, MN | 00 | 000000000000 | ||
0000000 | Venture Capital-Backed | Houston, TX | 00 | 000.00 | 0000000000 | 000.00 |
0000000 | Corporation | Danvers, MA | 0000 | 000.00 | 00000000000 | 000.00 |
OrganOx Patents
OrganOx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10362780-B2 | Oxygen supply for organ perfusion systems | Active | 10-Nov-2011 | 0000000000 | 0 |
CA-2855341-C | Oxygen supply for organ perfusion systems | Active | 10-Nov-2011 | 0000000000 | |
GB-2509875-A | Oxygen supply for organ perfusion systems | Granted | 10-Nov-2011 | 0000000000 | |
GB-2509875-B | Oxygen supply for organ perfusion systems | Active | 10-Nov-2011 | 0000000000 | |
ES-2711104-T3 | Oxygen supply for organ perfusion systems | Active | 10-Nov-2011 | A01N1/0247 |
OrganOx Executive Team (11)
OrganOx Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
Constantin Coussios Ph.D | Self | Co-Founder, Board Member & Chief Technical Officer | 000 0000 |
Craig Marshall | OrganOx | Chief Executive Officer & Board Member | 000 0000 |
George Robinson | Oxford Investment Consultants | Board Member | 000 0000 |
Graham Yeatman | OrganOx | Chief Financial Officer & Board Member | 000 0000 |
Juliet Thompson | OrganOx | Board Member | 000 0000 |
OrganOx Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOrganOx Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Perivoli Innovations Trust | Venture Capital | Minority | 000 0000 | 000000 0 | |
BGF | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
GT Healthcare Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Boost&Co | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | |
Oxford Investment Consultants | Venture Capital | Minority | 000 0000 | 000000 0 |